Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.
Patients who don't speak English face additional obstacles during their cancer journey but family, caregivers and the law are on their side.
The FDA is drafting new guidance on the use of external data in lieu of placebos in clinical trials. Please support this change.
EBCI is launching an initiative to bring more clinical trials of brain cancer treatments to the greater Puget Sound area, and to recruit and place qualified patients.
The EndBrainCancer Initiative Initiative recently hosted its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington
The EndBrainCancer Initiative is hosting its first ever GBM Patient & TOGETHER Day on Friday, March 15th at the Bellevue Club in Bellevue, Washington. Current and past brain cancer patients, survivors, caregivers, and families are invited to this special event
The EndBrainCancer Initiative received CITI certification to recruit caregivers to participate in brain cancer caregiver and patient clinical trials at the Pacific Neuroscience Institute and John Wayne Cancer Institute in conjunction with Providence Health Services of Southern California.
This article describes the potential for a significant shift in current standard of care. This includes discussions related to prior consent, immunotherapy, vaccines, devices, DNA sequencing/genomic profiling, MGMT testing and so on. It also includes discussions related to advanced treatments, targeted therapies and/or clinical trials prior to surgery.
Our collective awareness of this dreaded disease was heightened last week with the announcement that Senator John McCain will now be counted among the brave GBM warriors.
Celebrating the courage, grace, and selflessness of patients everywhere who battle cancer and participate in clinical trials. The wall was filled with notes from providers, families, and advocates.
It is time to take the politics out of brain cancer research, and for a good reason: to produce more survivors of the disease.
From the day it was founded in 2002, the EndBrainCancer Initiative | Chris Elliott Fund has been dedicated to changing how brain cancer is treated and to offering HOPE to brain cancer patients.
Gallery of slides detailing the strategy and priorities of the End Brain Cancer Initiative.
